| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6034267 | PHOTOCURE ASA | Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
Mar, 2016
(8 years ago) | |
| US7247655 | PHOTOCURE ASA | Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
Mar, 2016
(8 years ago) | |
| US7530461 | PHOTOCURE ASA | Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
Jan, 2017
(7 years ago) | |
| US7348361 | PHOTOCURE ASA | Solution for diagnosing or treating tissue pathologies |
Nov, 2020
(3 years ago) | |
| US11311620 | PHOTOCURE ASA | Neoadjuvant therapy for bladder cancer |
Dec, 2036
(12 years from now) | |
| US10556010 | PHOTOCURE ASA | Neoadjuvant therapy for bladder cancer |
Dec, 2036
(12 years from now) | |
| US11235168 | PHOTOCURE ASA | Method of photodynamic therapy (PDT) for bladder cancer |
Jan, 2038
(13 years from now) | |
Cysview Kit is owned by Photocure Asa.
Cysview Kit contains Hexaminolevulinate Hydrochloride.
Cysview Kit has a total of 7 drug patents out of which 4 drug patents have expired.
Expired drug patents of Cysview Kit are:
- US6034267
- US7247655
- US7530461
- US7348361
Cysview Kit was authorised for market use on 28 May, 2010.
Cysview Kit is available in for solution;intravesical dosage forms.
Cysview Kit can be used as detection of non-muscle invasive papillary cancer of the bladder by photodynamic cystoscopy, detection of carcinoma in the bladder by photodynamic cystoscopy.
The generics of Cysview Kit are possible to be released after 04 January, 2038.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| M(M-220) | Feb 15, 2021 |
| New Product(NP) | May 28, 2013 |
Drugs and Companies using HEXAMINOLEVULINATE HYDROCHLORIDE ingredient
Market Authorisation Date: 28 May, 2010
Treatment: Detection of non-muscle invasive papillary cancer of the bladder by photodynamic cystoscopy; Detection of carcinoma in the bladder by photodynamic cystoscopy
Dosage: FOR SOLUTION;INTRAVESICAL
CYSVIEW KIT family patents
